Roles of LncRNA ARSR in tumor proliferation, drug resistance, and lipid and cholesterol metabolism
Clinical and Translational Oncology · 09.09.2024 · 27 (4) · 1356-1365
DOI: 10.1007/s12094-024-03700-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, online erschienen am 09.09.2024. Verfasst von Zhicheng Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010050, Inner Mongolia, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Drug Resistance, Neoplasm, Lipid Metabolism, Cholesterol. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 108 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science Research Project of Inner Mongolia Autonomous Region, Inner Mongolia Autonomous Region health science and technology program.
Abstract (Originalsprache)
Cancer is one of the most serious diseases that threaten human life and health. Among all kinds of diseases, the mortality rate of malignant tumors is the second highest, second only to cardio-cerebrovascular diseases. Cancer treatment typically involves imaging, surgery, and pathological analysis. When patients are identified as carcinoma by the above means, there are often problems of distant metastasis, delayed treatment, and drug tolerance, indicating that patients have some poor prognosis and overall survival. Hence, the development of novel molecular biomarkers is of great clinical importance. In recent years, as an important mediator of material and information exchange between cells in the tumor microenvironment, lncRNA have attracted widespread attention for their roles in tumor development. In this review, we comprehensively summarize the up-to-date knowledge of lncARSR on diverse cancer types which mainly focuses on tumor proliferation, drug tolerance, and lipid and cholesterol metabolism, highlighting the potential of lncARSR as a diagnostic and prognostic biomarker and even a therapeutic target. In our final analysis, we provide a synthesized overview of the directions for future inquiry into lncARSR, and we are eager to witness the advancement of research that will elucidate the multifaceted nature of this lncRNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010050, Inner Mongolia, China.
- Department of Urology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010050, Inner Mongolia, China. 2728600785@qq.com.
Förderung
- National Natural Science Foundation of China
- Science Research Project of Inner Mongolia Autonomous Region
- Inner Mongolia Autonomous Region health science and technology program
Zitieren
APA
Li, Z., Wang, D., & Zhu, X. (2024). Roles of LncRNA ARSR in tumor proliferation, drug resistance, and lipid and cholesterol metabolism. Clinical and Translational Oncology, 27(4), 1356-1365. https://doi.org/10.1007/s12094-024-03700-4
Vancouver
Li Z, Wang D, Zhu X. Roles of LncRNA ARSR in tumor proliferation, drug resistance, and lipid and cholesterol metabolism. Clinical and Translational Oncology. 2024;27(4):1356-1365. doi:10.1007/s12094-024-03700-4
BibTeX
@article{Li2024,
author = {Li, Zhicheng and Wang, Dan and Zhu, Xiaojun},
title = {Roles of LncRNA ARSR in tumor proliferation, drug resistance, and lipid and cholesterol metabolism},
journal = {Clinical and Translational Oncology},
year = {2024},
volume = {27},
number = {4},
pages = {1356--1365},
doi = {10.1007/s12094-024-03700-4}
}
EUVIMED